Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 46, 2016 - Issue 8
Submit an article Journal homepage
120
Views
6
CrossRef citations to date
0
Altmetric
Pharmacogenetics

Genetic polymorphisms analysis of drug-metabolizing enzyme CYP2C9 in the Uyghur population

Tianbo JinKey Laboratory for Basic Life Science Research of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, ;Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, ;School of Life Sciences, Northwest University, Xi’an, Shaanxi, China, and ;National Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Xiaojie XunSchool of Life Sciences, Northwest University, Xi’an, Shaanxi, China, and ;National Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Shuli DuSchool of Life Sciences, Northwest University, Xi’an, Shaanxi, China, and ;National Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Tingting GengNational Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Hong WangNational Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Tian FengNational Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Chen ChenNational Engineering Research Center for Miniaturized Detection Systems, Xi’an, Shaanxi, China
,
Dongya YuanKey Laboratory for Basic Life Science Research of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, ;Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, Correspondence[email protected]
&
Longli KangKey Laboratory for Basic Life Science Research of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, ;Key Laboratory for Molecular Genetic Mechanisms and Intervention Research on High Altitude Disease of Tibet Autonomous Region, School of Medicine, Xizang Minzu University, Xianyang, Shaanxi, China, Correspondence[email protected]
 show all
Pages 709-714 | Received 29 Sep 2015, Accepted 30 Oct 2015, Published online: 26 Nov 2015

References

  • Adamec C. (1964). Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Cesk Zdrav 12:613
  • Adzhubei I, Jordan DM, Sunyaev SR. (2013). Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 7:7.20
  • Aynacioglu S, Brockmöller J, Bauer S, et al (1999). Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol 48:409–15
  • Barrett JC, Fry B, Maller J, Daly MJ. (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–5
  • Castelo-Branco BP, Choufani S, Mack S, et al (2013). Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. Lancet Oncol 14:534–42
  • Dai D, Xu R, Hu L, et al (2013). CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database. Pharmacogenomics J 14:85–92
  • Daly AK, King BP. (2006). Contribution of CYP2C9 to variability in vitamin K antagonist metabolism. Expert Opin Drug Metab Toxicol 2:3–15
  • Gaedigk A, Casley WL, Tyndale RF, et al (2001). Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. Can J Physiol Pharmacol 79:841–7
  • Kirchheiner J, Brockmöller LJ. (2005). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clin Pharmacol Ther 77:1–16
  • Kurose K, Sugiyama E, Saito Y. (2012). Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development. Drug Metab Pharmacokinet 27:9–54
  • Lee CR, Goldstein JA, Pieper JA. (2002). Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics 12:251–63
  • Lee H, Lim MS, Lee J, et al (2012). Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics. J Clin Pharm Ther 37:105–11
  • Li H, Cho K, Kidd JR, Kidd KK. (2009). Genetic landscape of Eurasia and ‘admixture’ in Uyghurs. Am J Hum Genet 85:934–7
  • Maekawa K, Fukushima Uesaka H, Tohkin M, et al (2006). Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese. Pharmacogenet Genomics 16:497–514
  • Meyer UA. (2000). Pharmacogenetics and adverse drug reactions. Lancet 356:1667–71
  • Ng PC, Henikoff S. (2002). Accounting for human polymorphisms predicted to affect protein function. Genome Res 12:436–46
  • Ng PC, Henikoff S. (2003). SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31:3812–14
  • Ng PC, Henikoff S. (2006). Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7:61–80
  • Schelleman H, Brensinger CM, Chen J, et al (2010). New genetic variant that might improve warfarin dose prediction in African Americans. Br J Clin Pharmacol 70:393–9
  • Scott SA, Khasawneh R, Peter I, et al (2010). Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics 11:781–91
  • Siddiqi A, Khan DA, Khan FA, Naveed AK. (2010). Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population. Pak J Pharm Sci 23:417–22
  • Takanashi K, Tainaka H, Kobayashi K, et al (2000). CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates. Pharmacogenetics 10:95–104
  • Tang C, Shou M, Rushmore TH, et al (2001). In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics 11:223–35
  • Van Booven D, Marsh S, Mcleod H, et al (2010). Cytochrome P450 2C9-CYP2C9. Pharmacogenet Genomics 20:277
  • Xiong Y, Wang M, Fang K, et al (2011). A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China. Genomics 97:277–81
  • Xu S, Huang W, Qian J, Jin L. (2008). Analysis of genomic admixture in Uyghur and its implication in mapping strategy. Am J Hum Genet 82:883–94
  • Zhou SF, Zhou ZW, Yang LP, Cai JP. (2009). Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem 16:3480–675
  • Zuo J, Xia D, Jia L, Guo T. (2012). Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations. Int J Pharm Sci 67:639–44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.